z-logo
open-access-imgOpen Access
Cost-effectiveness of olaparib versus routine surveillance in the maintenance setting for patients withBRCA-mutated advanced ovarian cancer after response to first-line platinum-based chemotherapy in Singapore
Author(s) -
David S.P. Tan,
Jack Junjie Chan,
Robert Hettle,
W Ghosh,
A Viswambaram,
Cindy Chen Yu
Publication year - 2021
Publication title -
journal of gynecologic oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.358
H-Index - 37
eISSN - 2005-0399
pISSN - 2005-0380
DOI - 10.3802/jgo.2021.32.e27
Subject(s) - medicine , olaparib , oncology , brca mutation , ovarian cancer , chemotherapy , first line , cancer , gynecology , poly adp ribose polymerase , gene , polymerase , biochemistry , chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here